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anatomical, neurochemical and electrophysiological changes of 
striatal glutamatergic transmission (Ingham et al., 1989; Stephens 
et al., 2005; Zaja-Milatovic et al., 2005; Smith and Villalba, 2008; 
Villalba et al., 2009).
The goal of this review is to provide an overall assessment of 
anatomical and functional evidence for spine loss in the striatum, 
and discuss the potential mechanisms involved in this pathophysi-
ological phenomenon in parkinsonism. The readers are referred 
to other recent reviews for additional information (Deutch et al., 
2007; Smith and Villalba, 2008; Smith et al., 2009).
Spine loSS in parkinSon’S DiSeaSe anD pD moDelS
Over the past decades, it became clear that the progressive loss of 
striatal dopamine in PD patients and animal models of parkinson-
ism results in a significant loss of dendritic spines on MSNs of the 
dorsal striatum (Figure 1).
The first clear evidence for striatal spine loss came from studies 
showing that unilateral degeneration of the nigrostriatal dopamin-
ergic system results in about 20% spine loss in the caudate- putamen 
complex  of  rats  treated  with  6-hydroxydopamine  (6-OHDA) 
(Ingham et al., 1989). Since then, corresponding degrees of spine 
pruning have been demonstrated in postmortem striatal tissue of 
PD patients (Stephens et al., 2005; Zaja-Milatovic et al., 2005) and 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (MPTP)-treated 
parkinsonian monkeys (Smith and Villalba, 2008; Villalba et al., 
2009). In monkeys and humans, the extent of spine loss correlates 
with the relative degree of striatal dopamine denervation (Zaja-
Milatovic et al., 2005; Smith and Villalba, 2008; Villalba et al., 2009). 
For instance, in MPTP-treated parkinsonian monkeys, MSNs in 
striatal regions most severely dopamine-depleted, like the postcom-
missural putamen (i.e., the sensorimotor striatum) lose as much 
as 50% spines, while spine loss in less affected striatal areas like the 
nucleus accumbens (i.e., the limbic striatum) ranges between 20% 
to 25% of total striatal spines (Villalba et al., 2009) (Figure 2).
introDuction
Since 1891 when Cajal described dendritic spines as morphologi-
cally distinct neuronal elements (Ramon y Cajal, 1891), studies 
of spine development, morphogenesis and plasticity have been 
at the forefront of research in various laboratories using modern 
techniques at the electron microscopic level for three-dimensional 
(3D) reconstructions of individual spines (Harris and Kater, 1994; 
DeFelipe, 2002; Smith et al., 2009; Villalba et al., 2010), single- 
and two-photon microscopy used in conjunction with fluorescent 
molecular tools (Yuste and Bonhoeffer, 2004; Knott and Holtmaat, 
2008) or neurocomputational methods (Zhang et al., 2010) to 
study dynamic changes in spine morphology related to pathologi-
cal or physiological regulation of neuronal plasticity (Yuste and 
Bonhoeffer, 2001).
Despite a broad range of experimental evidence showing changes 
in the density or morphology of dendritic spines in a large number 
of neurological and psychiatric diseases, the exact contribution of 
spine changes to brain diseases pathophysiology remains poorly 
understood (Ingham et al., 1989, 1998; Harris and Kater, 1994; Fiala 
et al., 2002; Picconi et al., 2005; Stephens et al., 2005; Zaja-Milatovic 
et al., 2005; Deutch et al., 2007; Surmeier et al., 2007; Bourne and 
Harris, 2008; Smith and Villalba, 2008; Villalba et al., 2009, 2010).
In the striatum, the principal neuronal subtypes are the medium 
spiny neurons (MSNs), which represent 95% of all striatal neurons 
(Kemp and Powell, 1971; Chang et al., 1982). In rats, each MSN 
harbors approximately 5000 dendritic spines (Wickens et al., 2007). 
Each of these spines receives glutamatergic inputs from the cerebral 
cortex or specific thalamic nuclei (Kemp and Powell, 1971; Smith 
et al., 2004, 2009; Raju et al., 2006). Spines are also an important 
target of midbrain dopaminergic inputs that play a critical role in 
the regulation of cortical glutamatergic afferents (Smith and Bolam, 
1990; Smith et al., 1994; Nicola et al., 2000). In both animal mod-
els of parkinsonism and Parkinson’s disease (PD) patients, MSNs 
lose as much 30–50% dendritic spines, which results in complex 
Striatal spine plasticity in Parkinson’s disease
Rosa M. Villalba1* and Yoland Smith1,2
1  Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA
2  Department of Neurology, Emory University, Atlanta, GA, USA
Striatal dopamine (DA) denervation results in a significant loss of dendritic spines on medium 
spiny projection neurons in Parkinson’s disease. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-
treated parkinsonian monkeys, spines contacted either by cortical or thalamic glutamatergic 
terminals are severely affected on both direct and indirect striatofugal neurons. In rodents, 
indirect pathway neurons appear to be more sensitive, at least in early stages of acute 
dopamine denervation.  The remaining corticostriatal and thalamostriatal axo-spinous synapses 
undergo complex ultrastructural remodeling consistent with increased synaptic activity in the 
DA-denervated primate striatum, which may explain the pathophysiological overactivity of the 
corticostriatal system reported in various animal models of parkinsonism.  The calcium-mediated 
regulation of the transcription factor myocyte enhancer factor 2 was recognized as a possible 
underlying mechanism for striatal spine plasticity. Future studies to determine how alterations 
in striatal spine plasticity contribute to the symptomatology of parkinsonism are warranted.
Keywords: dendritic spine, plasticity, dopamine, glutamate, Parkinson’s disease
Edited by:
Jose L. Lanciego, University of 
Navarra, Spain
Reviewed by:
Jose L. Lanciego, University of 
Navarra, Spain
José A. Armengol, University Pablo de 
Olavide, Spain
*Correspondence:
Rosa M. Villalba, Yerkes National 
Primate Research Center, Emory 
University, 954 Gatewood Rd. NE, 
Atlanta, GA 30329, USA. 
e-mail: rvillal@emory.eduFrontiers in Neuroanatomy  www.frontiersin.org  December 2010  | Volume 4  | Article 133  |  2
Villalba and Smith  Striatal spine plasticity
Data obtained so far about this issue remain controversial. On 
one hand, observations gathered from reserpine-treated mice and 
6-OHDA-treated rats suggested that D2-containing striatopalli-
dal neurons, but not D1-positive striatonigral neurons, selectively 
lose spines following dopamine depletion (Day et al., 2006). These 
observations are at odds with a large number of studies in both 
human parkinsonians and animal models of parkinsonism show-
ing a rather homogeneous loss of spines across large populations 
of Golgi-impregnated striatal MSNs (Ingham et al., 1989, 1998; 
Stephens et al., 2005; Zaja-Milatovic et al., 2005; Smith and Villalba, 
2008; Villalba et al., 2009). Furthermore, recent data from rhe-
sus monkeys chronically treated over many months with MPTP 
demonstrated  a  comparable  loss  of  both  D1-immunoreactive 
and D1-immunonegative spines in the DA-denervated putamen 
(Villalba et al., 2009), suggesting that spine pathogenesis affects 
both direct and indirect pathway striatofugal neurons in this ani-
mal model (Villalba et al., 2009). However, other monkey studies 
suggested a decrease in D2-positive spines accompanied with a 
This correlation has also been established in asymptomatic 
MPTP-treated monkeys with partial lesion of the nigrostriatal 
dopaminergic system, thereby suggesting that striatal spine loss 
may be an early pathology of parkinsonism that does not corre-
late with the severity of parkinsonian motor dysfunctions (Villalba 
et al., 2009).
are both “Direct” anD “inDirect” Striatofugal 
neuronS affecteD?
The basic model of direct and indirect pathways introduced in the 
late 1980s has been instrumental in our understanding of the basal 
ganglia circuitry, the pathophysiology of PD and the development 
of new therapeutic approaches for basal ganglia-related movement 
disorders (Albin et al., 1989; Bergman et al., 1990; Wichmann and 
Delong, 2007). Studies in animal models of PD suggest that striatal 
DA depletion results in an imbalance of activity between these two 
pathways in favor of an increased GABAergic striatal outflow from 
indirect pathway neurons combined with a decreased striatal output 
from direct pathway neurons, thereby leading to an overall increased 
tonic inhibition of thalamocortical neurons by basal ganglia outflow 
and resulting parkinsonian motor symptoms (Albin et al., 1989; 
DeLong, 1990; Obeso et al., 2000). Thus, taking into consideration 
that the activation of striatal MSNs rely on extrinsic glutamatergic 
inputs (Wilson, 1995), the possibility that spine loss affects preferen-
tially one population of striatal MSNs over the other in parkinson-
ism has generated considerable interest in recent years.
Figure 1 | The progressive striatal dopaminergic depletion in Parkinson’s 
disease (PD) patients and animal models of PD results in a severe spine 
loss in medium spiny neurons (MSNs) of the dorsal striatum. DA, 
dopamine; MSN, medium spiny neuron; PD, Parkinson’s disease.
Figure 2 | Dendrites from golgi-impregnated MSNs in the caudate 
nucleus of a control (A) and a MPTP-treated (B) monkey. Note the dramatic 
spine loss on the dendrite of the MSNs from the MPTP-treated monkey 
compared with control. Scale bar in (B) [valid for (A)]: 5 μm.Frontiers in Neuroanatomy  www.frontiersin.org  December 2010  | Volume 4  | Article 133  |  3
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Quantitative analysis of 3D-reconstructed axo-spinous cortico- 
and thalamostriatal analysis showed that the size of the postsynaptic 
density (PSD) area at both glutamatergic synapses is increased in 
the non-human primate model of PD, thereby suggesting that both 
thalamic and cortical inputs undergo plastic changes consistent 
with increased synaptic strength in parkinsonism (Smith et al., 
2009; Villalba et al., 2010) (Figure 4).
Our  data  also  revealed  that  the  complexity  and  the  total 
number of perforations at PSDs at corticostriatal and thalamos-
triatal glutamatergic synapses are increased in parkinsonism, a 
type of structural modification associated with increased synap-
tic efficacy and learning in the hippocampus (Nieto-Sampedro 
et al., 1982).
The exact mechanisms underlying these functional changes 
are not known, but it has been hypothesized that the compart-
mentalization of multiple transmission zones impedes the satu-
ration of postsynaptic receptors and allow multiple transmitter 
corresponding increase in D1-immunoreactive spines in the cau-
date nucleus of MPTP-treated cynomolgus monkeys (Scholz et al., 
2008). These apparent discrepancies may be due to the use of dif-
ferent animal models, different regimens of neurotoxin adminis-
tration, different quantitative methods to determine striatal spine 
loss and different striatal regions being examined.
DoeS Striatal Spine loSS affect preferentially 
cortical- over thalamic-recipient targetS?
The striatum receives glutamatergic inputs from the cerebral cortex 
and the thalamus. Although cortical inputs target almost exclusively 
dendritic spines, a substantial component of the thalamostriatal 
system that originates from the caudal intralaminar nuclei, center 
median and parafascicular nuclei, target preferentially dendritic 
shafts, whereas inputs from rostral intralaminar, relay and associative 
thalamic nuclei mainly innervate dendritic spines (Smith et al., 2004, 
2009; Raju et al., 2008). Although these two glutamatergic inputs 
cannot be differentiated from each other solely based on structural 
features, they can be categorized as of cortical or thalamic origin 
based on their specific expression in vesicular glutamate transporter 
1 (vGluT1) or vGluT2, respectively (Raju et al., 2006, 2008; Smith 
et al., 2009). Taking advantage of these specific markers, we recently 
reported a significant increase in the overall density of vGluT1-
positive terminals, but no significant change in the prevalence of 
vGluT2-positive boutons in the striatum of MPTP-treated parkin-
sonian monkeys (Raju et al., 2008). These findings are supported 
by postmortem human data showing an increased vGluT1 protein 
expression in the striatum of parkinsonians (Kashani et al., 2007).
At first glance, these observations are paradoxical to the fact 
that striatal MSNs undergo significant spine loss in parkinsonism, 
and that the bulk of synaptic inputs to striatal spines originate 
from cortical terminals (Kemp and Powell, 1971; Smith and Bolam, 
1990; Raju et al., 2008). However, they are consistent with a large 
number of electrophysiological and neurochemical studies that 
suggest an increased glutamatergic transmission at corticostriatal 
synapses and augmented neuronal excitability in the striatum of 
rodent models of parkinsonism (Gubellini et al., 2002; Mallet et al., 
2006, but see Day et al., 2006). Recent evidence suggests that such 
increased striatal activity may also occur in MPTP-treated mon-
keys (Liang et al., 2008). Although there is no clear explanation for 
this apparent discrepancy between morphological and functional 
data related to the corticostriatal system in parkinsonism, there are 
various indications that the striatum undergoes complex compen-
satory changes in glutamate receptors expression (Betarbet et al., 
2000) and synaptic architecture that may account for increased 
glutamatergic transmission in parkinsonian condition (see Smith 
et al., 2009, for a review).
ultraStructural reorganization of glutamatergic 
corticoStriatal anD thalamoStriatal SynapSeS in 
parkinSoniSm
Early rodent and human data, indeed, suggested morphologi-
cal changes of asymmetric synapses consistent with increased 
synaptic activity in the dopamine-denervated striatum (Ingham 
et al., 1998; Meshul et al., 1999, 2000). These observations were 
recently supported an expanded by detailed 3D ultrastructural 
analysis (Figure 3).
Figure 3 | electron micrograph and three-dimensional (3D) 
reconstruction of a corticostriatal (vgluT1-immunoreactive) axo-spinous 
synapse in the striatum of a MPTP-treated monkey. (A) Electron 
micrograph of a synapse between the spine of a MSN and a vGluT1-positive 
terminal (T). (B) 3D-reconstructed images from serial electron micrographs of 
the head (H) and neck (N) of the spine (B.1) and the axo-spine synapse (B.2) 
shown in (A). In (B.1), the spine is partially transparent to illustrate the 
complexity and distribution of the spine apparatus (SA) and the postsynaptic 
density (PSD). D, dendrite. Scale bar in (A): 1 μm.Frontiers in Neuroanatomy  www.frontiersin.org  December 2010  | Volume 4  | Article 133  |  4
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potential cellular, molecular anD genetic 
mechaniSmS for Striatal Spine loSS in parkinSon’S 
DiSeaSe
Despite clear evidence for major structural and functional plastic 
changes in glutamatergic transmission at axo-spinous synapses in 
the parkinsonian striatum, the mechanisms underlying this phe-
nomenon remain poorly understood. However, there is some indi-
cation that calcium likely contributes to this plastic event (Segal 
et al., 2000; Sabatini et al., 2001; Oertner and Matus, 2005; Day 
et al., 2006; Deutch et al., 2007; Surmeier et al., 2007). Findings in 
support of a calcium-regulated mechanism were recently gathered 
from transgenic mice with EGFP-labeled D1 or D2 DA receptors. 
In EGFP-D2 mice, spine loss can be prevented by genetic deletion 
of Cav1.3α1 subunits or the pharmacological blockade of L-type 
Cav1.3 channels (Day et al., 2006). Knowing that D2 dopamine 
receptor signaling targets only the channels that contain the 
Cav1.3α1 subunit (Surmeier et al., 2007),  these  data    suggest 
quanta to be effective at the same postsynaptic spine, thereby 
enhancing the strength of individual synapses (Lisman and Harris, 
1993). Thus, the extensive remodeling of PSDs at glutamatergic 
axo-spinous synapses in the striatum of parkinsonian monkeys 
provides  another  mechanism  whereby  cortical  and  thalamic 
glutamatergic afferents may increase their synaptic strength in 
parkinsonism (Figure 5).
Another  striking  change  observed  in  spines  that  receive 
vGluT1-containing cortical inputs in the striatum of MPTP-
treated monkeys is the massive growth of the spine apparatus 
at corticostriatal synapses (Villalba et al., 2010) These changes 
are consistent with increased protein synthesis and increased 
buffering of intraspinous calcium at glutamatergic synapses in 
other brain regions (Fifkova et al., 1983; Bourne and Harris, 
2008), thereby providing further evidence for increased corti-
costriatal glutamatergic transmission in parkinsonian condition 
(Gubellini et al., 2002).
Figure 4 | Histograms comparing the morphometric measurements 
(spine volume, PSD area, terminal volume) of structural elements at 
corticostriatal and thalamostriatal glutamatergic synapses using the 
3D reconstruction method of serial ultrathin sections collected from 30 
axo-spinous synapses in normal and MPTP-treated monkeys. (A) In 
control monkeys, the spine volume (Vol. Sp), the PSD areas and the size 
of pre-synaptic terminals at corticostriatal synapses are significantly larger 
than those at thalamostriatal synapses (*P < 0.001 for Vol. Sp. and 
PSD; *P = 0.016 for terminal; t-test). (B) The same is true for MPTP-
treated monkeys, except for the pre-synaptic terminals that do not display 
any significant size differences in this condition. (C,D) The spine volumes, 
the PSD areas and the volume of vGluT1- and vGluT2-containing terminals 
are significantly larger in MPTP-treated parkinsonian monkeys than in 
controls (*P < 0.001; t-test).Frontiers in Neuroanatomy  www.frontiersin.org  December 2010  | Volume 4  | Article 133  |  5
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that a dysregulation of calcium concentrations, preferentially in 
D2-containing striatopallidal neurons, may ultimately lead to 
specific spine loss on indirect pathway neurons in the rodent 
striatum (Day et al., 2006; Deutch et al., 2007; Surmeier et al., 
2007). Further support for the involvement of calcium in this 
process comes from observations showing that striatal areas poor 
in calbindin D-28k (CaB) (Francois et al., 1994), such as the post-
commissural putamen (sensorimotor striatal territory), are those 
that display the most severe striatal spine loss in MPTP-treated 
monkeys (Villalba et al., 2009). Recent data from co-culture stud-
ies suggest that the pruning of glutamatergic synapses and spines 
in the striatum, dependent upon calcium entry through L-type 
calcium channels, involves the activation of the Ca+2-dependent 
protein phosphatase, calcineurin and the up-regulation of the 
transcriptional activity of the myocyte enhancer factor 2 (MEF2). 
In turn, MEF2 up-regulation leads to increased expression of 
the Nurr77 and Arc genes linked to synaptic remodeling (Tian 
et al., 2010), thereby providing a signaling cascade through which 
striatal MSNs may undergo structural plasticity in parkinsonism 
(Tian et al., 2010).
It is noteworthy that MEF2 down-regulation is required for 
abnormal  outgrowth  of  spines  on  striatal  MSNs  in  cocaine-
treated animals (Pulipparacharuvil et al., 2008). Together, these 
data indicate that MEF2 plays a critical role in regulating striatal 
spine plasticity in pathological conditions. Cholinergic signaling 
through M1 muscarinic receptors and Kir2 potassium channels is 
another essential trigger for the pruning of glutamatergic synapses 
in models of parkinsonism (Shen et al., 2009).
Despite the lack of direct evidence that any of the gene muta-
tions characterized in PD underlie striatal spine loss, it is worth 
noting that PD-associated mutations that result in an increased 
kinase activity of Lrrk2 reduces neurite outgrowth in primary neu-
ronal cultures and in the intact rat CNS, whereas LRRK2 deficiency 
leads to increased neurite length and branching (MacLeod et al., 
2006). These findings, combined with evidence for strong Lrrk2 
expression in striatal MSNs (Lee et al., 2010) and Lrrk2 enzymatic 
activity toward protein complexes involved in the formation of 
actin-  enriched precursors of dendritic spines during neural devel-
opment (Parisiadou et al., 2009), suggest that LRRK2 mutation in 
PD may contribute to striatal spine pathology in these patients.
Figure 5 | Morphology of three-dimensionally reconstructed dendritic 
spines showing different types of postsynaptic densities (PSDs). (A,B) 
Macular (A) and fenestrated (B) PSDs from spines contacted by vGluT2-IR 
terminals in control (A) and MPTP-treated (B) monkeys. (C) Quantitative 
analysis of the two types of PSDs (perforated vs. macular) at corticostriatal 
and thalamostriatal axo-spinous synapses in control and MPTP-treated 
monkeys. (D) Comparative analysis of the relative percentages of PSDs 
with different number of perforations in spines contacted by vGluT1- or 
vGluT2-IR terminals in control and MPTP-treated parkinsonian monkeys. 
The proportion of complex PSDs (more than two perforations) is 
significantly increased (Pearson Chi-square analysis, χ2) in MPTP-treated 
animals at both corticostriatal (χ2 = 4.78; P = 0.03) and thalamostriatal 
(χ2 = 4.34; P = 0.035) axo-spinous synapses. Sp, spine; PSD, 
postsynaptic density.Frontiers in Neuroanatomy  www.frontiersin.org  December 2010  | Volume 4  | Article 133  |  6
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our laboratory and others showing the complex   ultrastructural 
compensatory changes that affect remaining glutamatergic syn-
apses in the dopamine-denervated striatum, we suggest that striatal 
MSNs are endowed with a high level of synaptic plasticity that 
allows sensorimotor-related information to be properly transmit-
ted and integrated at the striatal level despite a major reduction 
in the number of corticostriatal synapses, at least early in the dis-
ease process (Smith et al., 2009; Villalba et al., 2009). Whether this 
level of plastic compensation also applies to non-motor striatal 
areas to alleviate cognitive and limbic dysfunctions remains to be 
established.
In conclusion, striatal spine pathology provides further evidence 
that early striatal dysfunctions in dopaminergic and glutamatergic 
transmission are key elements of the complex pathophysiology of 
parkinsonism.
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concluDing remarkS
Striatal spine loss is a cardinal pathological feature of PD. Despite 
clear evidence that nigrostriatal dopaminergic lesion induces sig-
nificant striatal spine loss in various animal models of PD, there is 
no direct evidence that dopamine denervation is the causal factor 
of striatal spine pathology. In fact, recent in vitro and in vivo studies 
have indicated that striatal spine pruning of MSNs in response to 
dopamine denervation is significantly attenuated by cortical lesions 
(Neely et al., 2007; Garcia et al., 2010), suggesting that glutamatergic 
cortical inputs are essential to mediate striatal spine loss in parkin-
sonism. Thus, whether striatal spine loss is the consequence of the 
lack of dopamine-mediated effects on corticostriatal glutamatergic 
transmission or primarily induced by dysfunction of the corticos-
triatal system remains to be established (Smith et al., 2009).
Another poorly understood aspect of this striatal pathology is its 
functional significance in PD symptomatology. Our recent observa-
tions that partially lesioned MPTP-treated monkeys with 30–40% 
spine loss in the sensorimotor striatum (i.e., the postcommissural 
putamen), do not display any significant parkinsonian symptoms 
suggest that the loss of spines in the motor striatum is not suffi-
cient to elicit abnormal motor behaviors in parkinsonism (Smith 
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